(2628495), f. a. k., (8436039), K. J., (11640451), C. V., (3182421), M. P., (4490593), K. S., (21026864), A. H., . . . (20386236), B. C. (2025). Supplementary Material for: Aflibercept 2 mg for Neovascular Age-Related Macular Degeneration: XTEND at 3 Years.
Chicago Style (17th ed.) Citation(2628495), figshare admin karger, et al. Supplementary Material for: Aflibercept 2 Mg for Neovascular Age-Related Macular Degeneration: XTEND at 3 Years. 2025.
MLA (9th ed.) Citation(2628495), figshare admin karger, et al. Supplementary Material for: Aflibercept 2 Mg for Neovascular Age-Related Macular Degeneration: XTEND at 3 Years. 2025.
Warning: These citations may not always be 100% accurate.